Test-retest Study With [18F]FBB in Cardiac Amyloidosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Test-retest Study With [18F]FBB in Cardiac Amyloidosis — Stella

Recruiting

Back to Cardiac Amyloidosis trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United Kingdom

Royal Free Hospital, London

King's College London, London

Key details

Phase

Early testing

Sponsor

Life Molecular Imaging GmbH

Collaborators

pharmtrace

Enrollment target

~15 participants

Started

October 2025

Primary completion

September 2026

Age range

40 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov